Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles, Behavioral/Cognitive

The Impact of Dopamine on Aggression: An [18F]-FDOPA PET Study in Healthy Males

Thorben Schlüter, Oliver Winz, Karsten Henkel, Susanne Prinz, Lena Rademacher, Jörn Schmaljohann, Kai Dautzenberg, Paul Cumming, Yoshitaka Kumakura, Steffen Rex, Felix M. Mottaghy, Gerhard Gründer and Ingo Vernaleken
Journal of Neuroscience 23 October 2013, 33 (43) 16889-16896; DOI: https://doi.org/10.1523/JNEUROSCI.1398-13.2013
Thorben Schlüter
1Department of Psychiatry, Psychotherapy and Psychosomatics, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Winz
2Department of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karsten Henkel
1Department of Psychiatry, Psychotherapy and Psychosomatics, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Prinz
1Department of Psychiatry, Psychotherapy and Psychosomatics, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena Rademacher
1Department of Psychiatry, Psychotherapy and Psychosomatics, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jörn Schmaljohann
2Department of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Dautzenberg
2Department of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Cumming
3ABX Chemicals, 01454 Radeberg, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshitaka Kumakura
4Department of Nuclear Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, 113-8654 Tokyo, Japan,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steffen Rex
5Department of Anesthesiology, University Hospitals of the KU Leuven, 3000 Leuven, Belgium,
7Department of Anesthesiology, University Hospital of the RWTH Aachen University, 52074 Aachen, Germany, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix M. Mottaghy
2Department of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany,
6Jülich/Aachen Research Alliance (JARA), 52074 Aachen, Germany,
8Department of Nuclear Medicine, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Gründer
1Department of Psychiatry, Psychotherapy and Psychosomatics, and
6Jülich/Aachen Research Alliance (JARA), 52074 Aachen, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingo Vernaleken
1Department of Psychiatry, Psychotherapy and Psychosomatics, and
6Jülich/Aachen Research Alliance (JARA), 52074 Aachen, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • Correction: Schlüter et al., The Impact of Dopamine on Aggression: An [18F]-FDOPA PET Study in Healthy Males - January 17, 2018

Abstract

Cerebral dopamine (DA) transmission is thought to be an important modulator for the development and occurrence of aggressive behavior. However, the link between aggression and DA transmission in humans has not been investigated using molecular imaging and standardized behavioral tasks. We investigated aggression as a function of DA transmission in a group of (N = 21) healthy male volunteers undergoing 6-[18F]-fluoro-l-DOPA (FDOPA)-positron emission tomography (PET) and a modified version of the Point Subtraction Aggression Paradigm (PSAP). This task measures aggressive behavior during a monetary reward-related paradigm, where a putative adversary habitually tries to cheat. The participant can react in three ways (i.e., money substraction of the putative opponent [aggressive punishment], pressing a defense button, or continuing his money-making behavior). FDOPA-PET was analyzed using a steady-state model yielding estimates of the DA-synthesis capacity (K), the turnover of tracer DA formed in living brain (kloss), and the tracer distribution volume (Vd), which is an index of DA storage capacity.

Significant negative correlations between PSAP aggressive responses and the DA-synthesis capacity were present in several regions, most prominently in the midbrain (r = −0.640; p = 0.002). Lower degrees of aggressive responses were associated with higher DA storage capacity in the striatum and midbrain. Additionally, there was a significant positive correlation between the investment into monetary incentive responses on the PSAP and DA-synthesis capacity, notably in the midbrain (r = +0.618, p = 0.003). The results suggest that individuals with low DA transmission capacity are more vulnerable to reactive/impulsive aggression in response to provocation.

Introduction

Aggressive behavior is a prominent and challenging aspect of various mental disorders; furthermore, it is frequently encountered in healthy populations. However, the definition of what constitutes aggression is complex: among other classifications, the distinction between reactive aggression and instrumental aggression is very common. Reactive aggression is prototypically defined as offensive or violent behavior arising in response to frustrating or threatening events, with the primary intention to harm the adversary or oneself. In contrast, instrumental aggression is defined as serving the achievement of personal goals other than primarily inflicting harm (Berkowitz, 1993). In particular, reactive aggression has commonly been linked to increased impulsivity (Vitiello and Stoff, 1997). However, these phenomenological clusters are not linked directly to particular neurobiological pathways and mechanisms; the knowledge about such mechanisms is a matter of ongoing research. Likewise, the psychopharmacological tools for the treatment of pathological manifestations of aggression are insufficient (Rodrigo et al., 2010). Therefore, it is of high relevance to investigate the neurobiological processes involved in physiological forms of aggression. Mainly based on the phenomenon of impulsivity, previous neuropsychiatric research focused on the role of serotonin (Linnoila et al., 1983; Frankle et al., 2005; Witte et al., 2009; Rylands et al., 2012). Nonetheless, it is known that the dopamine (DA) system is highly involved in behavioral control encoding reward expectancies and prediction errors (Schultz, 2002). Aggression frequently arises in contexts where an individual competes with others for rewards or if the expectation of a reward is frustrated or threatened by others. Accordingly, results from animal studies suggest an association between DA and aggression (Ferrari et al., 2003; Couppis and Kennedy, 2008; Anstrom et al., 2009). The few investigations in humans of possible DA/aggression associations point in the same direction (Licata et al., 1993; Soderstrom et al., 2001; Ramirez-Bermudez et al., 2010).

Questionnaires, in particular self-report scales, used in many studies of human aggression are, however, prone to subjectivity and social desirability. Until now, there are no investigations that directly link observable (provoked) aggressive behavior and molecular imaging of the DA system. A frequently used and well validated experimental paradigm for studying aggressive behavior is the Point Subtraction Aggression Paradigm (PSAP; Cherek et al., 1997).

To investigate the relationship between aggression and presynaptic trait parameters of DA transmission we assessed in a series of healthy volunteers the PSAP, and in the same subjects acquired positron emission tomography (PET) scans using the DOPA decarboxylase substrate 6-[18F]-fluoro-l-DOPA (FDOPA). A steady-state kinetic analysis was performed yielding individual estimates of a triad of kinetic terms, i.e., the net blood–brain clearance of FDOPA (K), which indicates DA-synthesis capacity, the washout rate of decarboxylated FDOPA metabolites (kloss), which reflects DA turnover, and the total distribution volume of FDOPA (Vd), which is an index of regional DA storage capacity (Vernaleken et al., 2006, 2008; Kumakura et al., 2007). We used a correlational analysis to test the hypothesis that higher subcortical DA synthesis and turnover is associated with greater aggressive responding on the PSAP.

Materials and Methods

The study was approved by the Ethics Committee of the RWTH University and the German radiation safety authorities in accordance with national and international standards.

Participants.

A group of 22 healthy male subjects was included in the investigation after written informed consent to participate in the study. The age of the subjects ranged from 20 to 39 years (mean: 25.2; SD: 4.8). One participant's data had to be excluded because he obtained insight into the absence of any real human counterpart (v.i.) in the behavioral test of aggression, which requires belief in the deception to be valid. The final sample (n = 21) had a mean age of 25.5 ± 5.5 years (mean ± SD), and consisted of subjects of comparable socioeconomic status (19 participants had a school education of 13 years, whereas 2 had a school education of 10 years); this was intended because the cognitive performance was previously reported to be highly correlated with the DA-synthesis capacity (Vernaleken et al., 2007). Due to the consequently very low variance, age and education were not included as covariates in the final analysis. Physical and mental-state examinations, drug screenings, and blood and urine analyses, as well as electrocardiography and electroencephalography examinations were performed. An experienced psychiatrist screened the participants to ensure the absence of any mental disorder, known family history of mental disorders that required treatment, substance abuse or relevant somatic complaint, any central acting substance for at least 6 weeks, and any medication during the week of the PET scan. A T1-weighted 3D gradient echo magnetic resonance scan was performed to check for possible anatomical abnormalities and for the purposes of anatomical coregistration of the PET data (v.i.). Participants underwent a single FDOPA-PET scan, as described below. The PSAP was performed directly before (n = 16) or after (n = 5) the PET-scan. The respective real-money earnings were paid by cash directly after completion of the paradigm. Furthermore, individual personality traits were characterized using the Temperament and Character Inventory (Cloninger, 1994, 1999).

The PSAP.

The PSAP is a computer-based behavioral paradigm that measures aggressive as well as defensive behavior in participants. The paradigm was programmed using Presentation software (V14.7; Neurobehavioral Systems). The composition of the PSAP was adopted with minor modifications from Cherek et al. (1990, 1997) and Bjork et al. (1999). In brief, the participant was instructed that he can earn real money (by pressing a button ∼100 times) at a rate of 40 cents for each completed sequence. Furthermore, he is told that an unseen opponent has also been instructed to earn money by bar pressing. The putative counterpart is said to be able to interfere with the real participant's game by cheating so as to steal 40 cent sums from the participant's account; this was in fact performed automatically at random intervals of 6–120 s. The participant is provided with the options either to shield (for an uncertain interval) his account against the counterpart's cheating by pressing a second button ∼10 times (defensive response), or alternatively to penalize the fictive counterpart by 100 cents by pressing a third button (aggressive response) 10 times. The participant was explicitly informed that this sum was not credited to his (the participant's) account. To ensure comprehension of the task, the experimenter asked the participants to explain the rules directly before the PSAP was started. If necessary, he then repeated the rules. During the game the earned and lost money was continuously presented to the participant on the display.

When either an aggressive or a defensive response has been completed, any scheduled provocation (point subtraction from the participant's account) is prevented for a provocation free interval (PFI) of 62.5 s (rather than 250 s as in the original version). This interval of 62.5 s is adapted from other studies (New et al., 2009; Greenwald et al., 2011) that also applied only a single session of the PSAP. Thus, aggressive actions of the participant may create the impression that this strategy has an impact on the (fictive) adversary's behavior. After the PFI has ended, new provocations can be scheduled. However, in the case of defensive responding, the PFI is only enabled if at least one provocation has occurred previously. Importantly, the participant is not informed about the PFI. He is informed that in case of a defensive action his account would be protected for an “unknown” amount of time by attacks from the other player. In case of an aggressive response, he is not instructed that a PFI may be the result of this action since a general rule of aggression-associated PFIs would argue against the existence of a real counterpart.

Theoretically, results of the paradigm are dependent on how fast a participant presses the buttons (pressing speed). To correct for interindividual differences in pressing speed, a limitation was implemented, comparable to the one of Cherek et al. (1990): if the time difference between two consecutive button presses was <170 ms, the number of button presses to be made for completion of the respective action (monetary, defensive, aggressive) increased accordingly. This modification served to balance differences in bar-pressing speed between participants. Completion of the PSAP test required 25 min, after which the participants were asked to describe the putative opponent's behavior, and to judge who had succeeded in stealing more money from his respective counterpart. If the answers implied doubts about the existence of a real human counterpart, the deception was evaluated as unsuccessful.

The main outcome variables of the PSAP, i.e., the total completed aggressive responses (TAR), the total completed defensive responses (TDR), and the total completed monetary responses (TMR), were transformed into ratios relative to the sum of all completed actions as follows: (1) aggressive ratio: the ratio of TAR to the total number of completed responses = TAR/(TAR + TMR*10 + TDR), (2) defensive ratio: the ratio of TDR to the total number of completed responses = TDR/(TAR + TMR*10 + TDR), and (3) monetary ratio: the ratio of TMR to the total number of completed responses = 10*TMR/(TAR + TMR*10 + TDR).

In its original version, the PSAP was repeated six times and the scores were averaged across these sessions (Cherek et al., 1997). In recent studies, the PSAP has been reduced to a single session. A report by Golomb et al. (2007) shows reliability of this simplified approach. These studies used shorter PFIs to ensure that participants were confronted with sufficient provocations. The PFI (62.5 s) of the present study was adapted from Greenwald et al. (2011).

Post hoc manipulation of PSAP.

Driven by the results (see below), a second group of 20 subjects of demographics highly comparable to the first was invited to perform the PSAP in a slightly modified version. This version was tested to test whether a more competitive environment might have a significant influence on the aggressive behavior. These subjects did not receive PET scans but were additionally characterized by the Psychopathy Personality Inventory Revised (Hare et al., 1991) and the Proactive–reactive Aggression Questionnaire (RPQ; Raine et al., 2006). Their mean age was 24.7 ± 3.2 years (range 20–32 years). Eighteen of 20 subjects were students, one person was used, and another was seeking employment. All subjects were male, nonsmoking, and free of any mental and relevant somatic complaints. The PSAP was performed with the same parameters and instruction as mentioned before, except that the participants were told that they would receive money only if they defeated the fictive opponent. None of the subjects had previous knowledge of the PSAP.

PET data acquisition.

All PET recordings were obtained using an ECAT HR+ (Siemens) whole-body PET scanner in 3D mode. Decarboxylation of FDOPA in peripheral tissues was reduced by oral administration of carbidopa (Lodosyn; Merck) in a divided dose of 100 mg 1 h before the scan and 50 mg directly before the tracer injection. After a 10 min attenuation scan, a mean of 236 MBq FDOPA (SD: 11 MBq, range: 216–255 MBq) was injected as a slow intravenous bolus into a cubital vein. A sequence of 30 emission frames lasting a total of 124 min was recorded. Frame length increased progressively according to the following schedule: 3 × 20 s 3 × 1 min, 3 × 2 min, 3 × 3 min, 15 × 5 min, and 3 × 10 min. During this recording, arterial blood samples were withdrawn via a catheter placed in a radial artery by an anesthesiologist. Continuous automated blood sampling (Allogg ABSS V3) during the first 10 min was followed by manual sampling at intervals of 5–10 min: a total of 17 2 ml blood samples were withdrawn for measuring the plasma radioactivity curve, and seven additional 5 ml samples were withdrawn for HPLC analysis of FDOPA and 3-O-methyl-[18F]fluorodopa (OMFD) fractions. Upon completion of the PET recording the arterial catheter was removed and a pressure bandage was applied, with monitoring for at least 10 min for any adverse affects.

Image analysis.

Individual emission images were reconstructed using the filtered back projection, using a 4 mm Hanning filter. Framewise motion correction was performed, using an interframe rigid-body transformation as implemented in PMOD (PMOD Technology). For spatial normalization, the PET image was first coregistered to the individual magnetic resonance tomographic (MRT) image, which was then normalized to the ICBM 452 template (Mazziotta et al., 2001) using PMOD (Brain Normalization II routine). Time activity curves (TAC) were calculated for a standard set of volumes of interest (VOI) (Gründer et al., 2008) including the cerebellum (2.38 cm3), the caudate nucleus (NC; 0.52 cm3), the putamen (1.14 cm3), the thalamus (2.50 cm3), and midbrain (0.252 cm3). For four participants with contraindications against MR tomography, PET images were normalized to a standard FDOPA template.

HPLC analysis of FDOPA and metabolite fractions.

HPLC was used to determine the FDOPA and metabolite fractions in plasma extracts from arterial blood collected at seven time points based on previous methods (Cumming et al., 1993). Additional solid phase extractions (Boyes et al., 1986) were performed at 12 additional time points. Continuous FDOPA and OMFD fractions were calculated by bi-exponential fitting of the measured fractions, and the corresponding arterial input curves were calculated as described previously.

FDOPA kinetics.

The kinetic analysis of the FDOPA-TACs was performed by application of the reversible “inlet-outlet-model” (IOM) as described previously (Kumakura et al., 2005, 2006). In brief, this approach comprises two modeling steps. First, an input curve of the radiolabeled metabolite OMFD is calculated using a one-tissue compartment model applied to the cerebellum VOI (Gjedde et al., 1991; Huang et al., 1991). In contrast to several standard procedures, rather than subtracting the entire cerebellar TAC, only the OMFD TAC is subtracted from the telencephalic VOI TACs. In step 2, these OMFD-cleaned TACs are then analyzed using a multilinear two-compartment model to determine the regional outcome parameters. This procedure avoids the usual oversubstraction of precursor pool in cerebellum subtraction methods. Consequently, regions with lesser [18F]FDOPA uptake (midbrain, thalamus) can be readily analyzed in addition to the extended striatum. Furthermore, the IOM enables the calculation of a triad of steady-state FDOPA kinetic parameters during a 2 h scan acquisition: (1) the intrinsic blood–brain clearance of FDOPA (K, ml g−1 min−1), which is an index of DA-synthesis capacity; (2) the washout rate for [18F]fluorodopamine (kloss; min−1), which is an index of dopamine turnover; and (3) the steady-state distribution volume of FDOPA together with its decarboxylated metabolites (Vd; ml g−1), which is an index of DA storage capacity, comparable to the effective distribution volume (ml g−1), as defined by Sossi et al. (2001).

Statistical analyses.

The three IOM FDOPA parameters of interest (K, kloss, and Vd) were calculated for each VOI and then correlated with scores for aggressive, monetary, and defensive responding on the PSAP. Because the majority of the PSAP variables were not normally distributed, the rank-order correlation by Spearman was used. For the same reason the rank-order correlation was the chosen tool for assessing the relationships between personality factors, IOM parameters, and PSAP variables. The significance level for the statistical tests was set to 0.05. A Bonferroni correction was applied for correction of multiple testing. However, the Bonferroni method does not account for high intercorrelations between the respective variables; therefore the proposed α values are overly conservative in the present case.

Results

Twenty-one subjects successfully completed the PET scan and the PSAP. The mean net blood–brain clearance (K) was 0.0076 ± 0.0030 [ml g−1 min−1] in the midbrain, 0.0184 ± 0.0039 [ml g−1 min−1] in the NC, and 0.0213 ± 0.0044 [ml g−1 min−1] in the putamen. The corresponding kloss values were 0.0058 ± 0.0062 [min−1] in midbrain, 0.0034 ± 0.0011 [min−1] in NC, and 0.0042 ± 0.0012 [min−1] in putamen (for details, including Vd-results, see Table 1). The K values were normally distributed in the NC, putamen, and thalamus but right skewed in the midbrain (see Table 1).

View this table:
  • View inline
  • View popup
Table 1.

Regional FDOPA kinetic results according to the reversible inlet–outlet model

The population mean (±SD) of total completed aggressive responses (TARs) was 15.5 ± 19.5. The corresponding population means of completed defensive responses (TDRs) and completed monetary responses (TMR) were 49.6 ± 24.6 and 68.0 ± 5.8, respectively. Details of Aggressive Ratio, Monetary Ratio, and Defensive Ratio results are reported in Table 2. One subject showed fairly high rates of TAR and TMR (outside the 1.5 interquartile range). Since there were no grounds for alleging his insight into the paradigm, there was no reason for exclusion of this subject. Additionally, the rank-order correlation is known to be very robust against skewness. Nevertheless, statistics that might be affected by this outlier were calculated with and without his exclusion.

View this table:
  • View inline
  • View popup
Table 2.

Results from the Point Subtraction Aggression Paradigm (PSAP)

There were significant correlations between Aggressive Ratio and the corresponding individual K values in the midbrain, NC, and putamen. The relationship was strongest in the midbrain (r = −0.640, p = 0.0002; n = 21; after outlier exclusion: r = −0.592, p = 0.006; n = 20; two-tailed rank-order correlation) (see Table 3, Fig. 1). Defensive Ratio, correlated at trend level with K in the midbrain (r = −0.409, p = 0.066; n = 21; two-tailed rank-order correlation). There was a strong and significant positive correlation between Monetary Ratio and regional K values in the midbrain (r = 0.618, p = 0.003; n = 21; after outlier exclusion: r = 0.560, p = 0.010; n = 20; two-tailed rank-order correlation). PSAP parameters did not correlate significantly with regional estimates of kloss and Vd, except for the correlation between Aggressive Ratio and Vd in thalamus (r = −0.523, p = 0.015; n = 21; after outlier exclusion: r = -.417, p = 0.067; n = 20; two-tailed rank-order correlation; Fig. 1). The main TCI variables did not correlate significantly with regional FDOPA parameters.

View this table:
  • View inline
  • View popup
Table 3.

Rank-order correlations between PSAP ratio variables and regional dopamine intrinsic synthesis capacity (K-values)

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A, Relationship between the aggressive response ratio (Aggressive Ratio) and FDOPA-Vd (ml g−1; index of dopamine storage capacity) in NC, thalamus, and midbrain; correlation in thalamus reached significance (r = −0.497, p = 0.022; n = 21; two-tailed rank-order correlation). B, Relationship between Aggressive Ratio and FDOPA-K (ml g−1 min−1; index of dopamine synthesis capacity). Significant correlations in the NC (r = −0.444, p = 0.044; n = 21; two-tailed rank-order correlation) and midbrain (r = −0.640, p = 0.0002; n = 21; two-tailed rank-order correlation). For illustration, the solid line represents the linear regression line.

Any before mentioned significant correlation between K and the ratios (monetary, aggressive, and defensive) remained significant if including the absolute number (instead of the ratios) of the respective button actions (see Table 4), nor was the correlation between Vd in the thalamus and aggression affected by this consideration/factor (r = −0.519, p = 0.016; n = 21; two-tailed rank-order correlation).

View this table:
  • View inline
  • View popup
Table 4.

Rank-order correlations between PSAP total completed responses variables and regional dopamine intrinsic synthesis capacity (K values)

Intraindividual rank-order correlations between the PSAP variables showed a significant negative association between Monetary Ratio and Defensive Ratio (r = −0.911, p < 0.001; n = 21; after outlier exclusion: r = −0.897, p < 0.001; n = 20; two-tailed rank-order correlation). The correlation between Aggressive Ratio and Monetary Ratio was borderline significant (p = 0.083), whereas there was no association between Aggressive Ratio and Defensive ratio (see Table 5). For correlations with earnings and number of provocations (= “Subtractions”) see Table 5.

View this table:
  • View inline
  • View popup
Table 5.

Rank-order correlations between PSAP Ratio variables

Although the regional outcome parameters are apparently not independent from each other, we also conducted a Bonferroni correction for our main results considering four brain regions (NC, putamen, midbrain, and thalamus) and three behavioral outcome values (Aggressive Ratio, Monetary Ratio, and Defensive Ratio). The corresponding corrected α level is p = 0.004. Due to the above-mentioned interrelations of these parameters, this approach is highly conservative. However, even using this overly conservative correction, the correlations between Aggressive Ratio, Monetary Ration, and midbrain K remained significant.

Second PSAP group analysis

The additional group of 20 subjects undergoing the PSAP under competitive conditions showed total completed aggressive responses (TAR) of 33.9 ± 34.3 (mean, SD). The corresponding population means of completed defensive responses (TDR) and completed monetary responses (TMR) were 67.1 ± 31.0 and 60.9 ± 9.3, respectively, giving ratios of 0.05, 0.10, and 0.86, respectively. Compared with the behavior of those individuals who (or study group that) performed the PSAP in the original version, there was a significantly higher Aggressive Ratio response (t = 2.14, p = 0.039, n = 41, t test of independent samples). Furthermore, the RPQ proactive questionnaire correlated positively with the Aggressive Ratio (r = 0.514, p = 0.025; n = 20 two-tailed Pearson correlation), whereas the reactive RPQ did not (r = 0.298, p = 0.215; n = 20 two-tailed Pearson correlation).

Discussion

This investigation focused on the relationship between observable provoked aggressive behavior and in vivo parameters reflecting the functional state of the subcortical dopamine system. The main finding is the negative correlation between aggressive actions (Aggressive Ratio) and the subcortical (particularly the midbrain) DA-synthesis capacity. Conversely, the rate of pressing the money-earning bar correlated positively with the DA-synthesis capacity. Even after correction for multiple testing, these associations remained significant for the midbrain region.

The PSAP was frequently applied before: Greenwald et al. (2011) showed that prenatal cocaine exposure led to increased escape behavior and New et al. (2009) linked aggressive behavior with clinical and brain metabolic dimensions of intermittent explosive disorder. These and similar investigations (Coccaro et al., 1996; Moeller et al., 1996; Bjork et al., 1999; Kouri et al., 1999; Pope et al., 2000) confirm its reliability and construct validity. It provides insight into directly observable behavior in “near real-life conditions.” Questionnaires may show high reliability but suffer from less validity and the problem of social desirability (Henry and Study Research Group TMAC, 2006).

Two issues arise from the strong negative associations: (1) the type of aggression indexed by the present version of the PSAP is uncertain and (2) the present data are difficult to integrate into animal findings of DA/aggression associations, which rather hint toward a positive direction.

Frequently two types of aggression were defined (instrumental/proactive vs impulsive/reactive; Atkins et al., 1993; Berkowitz, 1993; Vitiello and Stoff, 1997). Thus, lower aggression scores could either reflect a weaker drive for goal-directed attacks (instrumental), or a higher resilience against frustrations (less vulnerability to impulsive aggression). In the latter case, subjects with higher DA-synthesis capacity would maintain money-earning behavior and resist the impulse of delivering punishment after weighing the monetary effect of the possible actions. The participant's reward expectancy should initially be focused on money bar pressing. Importantly, the participant is not instructed that aggressive actions are beneficial since the knowledge about automated aggression associated PFIs would act against a convincing illusion of a real counterpart. At least at the beginning of the test, the participant could not predict the effect of his actions; in fact, there was not the slightest correlation between final earnings and Ratio Aggression; i.e., aggressive behavior was not actually rewarded or detrimental. Given that the participant could not expect a straightforward beneficial effect of aggressive actions, the PSAP in the present version reflects more reactive sources of aggression. Thus, subjects with higher DA-synthesis capacity in subcortical structures–subserving higher reward expectancy–might refrain from being distracted by provocations and time-consuming defense strategies. This distraction does not necessarily lead to aggressive but also to defensive strategies. Accordingly, we found a negative correlation between the midbrain K and Defensive Ratio. Subjects with higher DA-synthesis capacity, however, show higher resilience in maintaining their original money-earning behavior. Therefore, the PSAP results should be highly sensitive to the instructions and rules of the paradigm.

To test this sensitivity, a slightly modified PSAP paradigm was tested post hoc in a second group of subjects, without PET acquisition: a small change in the instructions (money will only be paid if the enemy is defeated) caused increased aggression, although the social background and mental state was similar in the two samples. Direct competition subserved utilization of proactive aggressive behavior (positive association between Aggressive Ratio and RPQ proactive rating). Furthermore, previous investigations have shown that harm or misfortune befalling another person is experienced as more rewarding if the observer considered himself to be in direct competition with the unfortunate counterpart (de Bruijn et al., 2009; Takahashi et al., 2009). In the PET participants, however, high DA-synthesis capacity was associated with the expectancy of monetary incentives to be obtained by nonaggressive actions, without resorting to more aggressive and socially less accepted patterns of behavior. It might be hypothesized that with a higher degree of direct competition, aggression could be under positive dopaminergic control.

Furthermore, why has research in animals found overt aggression (Ferrari et al., 2003; Couppis and Kennedy, 2008; Anstrom et al., 2009) to be associated with increased DA transmission? For rodents, food and sex are the most important incentives, access to which depends on the individual's position in a group hierarchy, which is organized by aggression or dominant stance. Prodopaminergic parameters appear to be positively associated with hierarchic position among nonhuman primates (Morgan et al., 2002). Furthermore, the linkage between aggression and reward expectancy appears to be more straightforward in the repertoire of animals than in humans.

Aggression in humans is one of the possible approaches to achieve aspired goals (Blanchard and Blanchard, 2003); it is broadened by culturally defined (and potentially more effective) behavioral alternatives. The latter condition might be reflected by the bar-pressing behavior (work) for monetary payoffs. This flexibility of diverse behavioral choices has an important impact on the participant's decision making during the PSAP. Increasing its competitive character appears to facilitate more aggressive strategies, which might be usually suppressed in normally socialized subjects (in absence of plain rewards). Furthermore, many animal investigations focus on DA release during aggressive actions, whereas our PET scans were not acquired during PSAP performance, which is presumed to reveal trait markers rather than state markers of aggression; we cannot make any claims about phasic DA release during punishment in the PSAP. Finally, monetary reward is a non-natural incentive. Nonetheless, its effect on reward systems (Ernst et al., 2004; Rademacher et al., 2010) is comparable to that evoked by food-related expectancies (O'Doherty et al., 2002) or sexual incentives (Oei et al., 2012).

Dopaminergic transmission impacts impulsivity, which can affect aggressive actions. In animals, stimulants seem to increase premature responses but decrease signaled delay-discounting impulsivity, whereas such drugs have minimal effect on motor impulsivity (Dalley and Roiser, 2012). Similarly, on a delay-discounting task in humans, increasing cortical DA levels by treatment with a COMT inhibitor decreases impulsivity and increases task-dependent blood oxygenation level-dependent activity in the left ventral striatum and the insula (Kayser et al., 2012). Studies using only questionnaires for behavioral characterization, however, do not show an unequivocal pattern: whereas Buckholtz et al. (2010) found amphetamine-associated DA release to be positively correlated with the Barrett Impulsiveness Scale and Oswald et al. (2007) found DA release to be negatively correlated with impulsivity (NEO PI-R).

Several PET investigations reported increased DA transmission during reward expectancy (gambling) in various populations, in a manner depending on the win/loss relationship (Linnet et al., 2011; Joutsa et al., 2012). With regard to coping with uncertainties, some studies have proposed a positive association between DA transmission and risk seeking (Cocker et al., 2012; Linnet et al., 2012). The PSAP is no gambling or delay-discounting task. Nevertheless, the counterpart's cheating can be interpreted as uncertainty, whereas the requirement of repeated bar pressing can be regarded as delayed reward. Thus, the present data are consistent with DA-driven decreased impulsivity or rather that DA imparts greater disposition to deal with uncertainties (resilience against provocations). In ADHD, a disorder with decreased subcortical DA-synthesis capacity (Ludolph et al., 2008), deficits in DA signals during reinforcement learning might interfere with delay discounting (Tripp and Wickens, 2008). These considerations are necessarily simplistic and neglect any possible rewarding effects of punishment and any influence of DA on emotional processing, defensive and aggressive actions.

There are methodological limitations of our study: PSAPs were in 16/21 cases administered directly before PET scans, which may have theoretically perturbed DA transmission measured 1 h later. However, DA-synthesis capacity is a very stable parameter, and task-dependent changes in the magnitude of K were never reported. In previous investigations, DA-synthesis capacity correlated with stable trait parameters of healthy subjects, whereas strong pharmacological challenges are necessary to cause significant changes in K (Vernaleken et al., 2008). For kloss, an order effect cannot fully be excluded. In general, FDOPA kinetics is difficult to interpret since DOPA decarboxylase is not the rate-limiting enzyme of DA synthesis. Nevertheless, its activity determines the fraction of endogenous l-DOPA trapped as DA (Cumming and Gjedde, 1998). K represents the capacity to use FDOPA in brain, whereas kloss and Vd are sensitive to pharmacological challenges (Schabram et al., 2013). In the present study, these more state-dependent kinetic parameters scarcely correlated with the PSAP results, suggesting that behavioral traits in the spectrum of aggression were almost exclusively linked to trait DA-synthesis capacity.

The present group size is larger than in many PET studies, but is small for the usual requirements of behavioral testing. A power analysis reveals a probability of 61% to reject a true correlation with ρ ≥ 0.5. Nevertheless, the correlational analyses indicated that ∼40% of variability in provoked aggressive behavior could be attributed to FDOPA-PET results. This might be due to the homogenous composition of the study group. Age and education ranges were restricted to decrease respective confounds. Another limitation is the inclusion of smokers (6/21) (Salokangas et al., 2000). However, a split analysis of smokers and nonsmokers did not indicate group differences in any parameter.

This investigation constitutes one of the first studies showing a relationship between neurobiological in vivo parameters and the results of a complex behavioral task, with particular implications for the neurochemical basis of human aggression.

Footnotes

  • This work is funded by the Deutsche Forschungsgemeinschaft (GR1399/7-1); the Project House “Interdisciplinary Management Practice,” Aachen (IMP-12); and the Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University, Germany (VBAI N4-5). We thank the Brain Imaging Facility of the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University, Germany, for support.

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Dr. Ingo Vernaleken, Department of Psychiatry, Psychotherapy, and Psychosomatics, RWTH Aachen University, Pauwelsstrasse 30, D-52074 Aachen, Germany. ivernaleken{at}ukaachen.de

References

  1. ↵
    1. Anstrom KK,
    2. Miczek KA,
    3. Budygin EA
    (2009) Increased phasic dopamine signaling in the mesolimbic pathway during social defeat in rats. Neuroscience 161:3–12, doi:10.1016/j.neuroscience.2009.03.023, pmid:19298844.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Atkins MS,
    2. Stoff DM,
    3. Osborne ML,
    4. Brown K
    (1993) Distinguishing instrumental and hostile aggression: does it make a difference? J Abnorm Child Psychol 21:355–365, doi:10.1007/BF01261598, pmid:8408984.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Berkowitz L
    (1993) Pain and aggression: some findings and implications. Motiv Emot 17:277–293, doi:10.1007/BF00992223.
    OpenUrlCrossRef
  4. ↵
    1. Bjork JM,
    2. Dougherty DM,
    3. Moeller FG,
    4. Cherek DR,
    5. Swann AC
    (1999) The effects of tryptophan depletion and loading on laboratory aggression in men: time course and a food-restricted control. Psychopharmacology 142:24–30, doi:10.1007/s002130050858, pmid:10102779.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Blanchard DC,
    2. Blanchard RJ
    (2003) What can animal aggression research tell us about human aggression? Horm Behav 44:171–177, doi:10.1016/S0018-506X(03)00133-8, pmid:14609539.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Boyes BE,
    2. Cumming P,
    3. Martin WR,
    4. McGeer EG
    (1986) Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects. Life Sci 39:2243–2252, doi:10.1016/0024-3205(86)90403-0, pmid:3097437.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Buckholtz JW,
    2. Treadway MT,
    3. Cowan RL,
    4. Woodward ND,
    5. Li R,
    6. Ansari MS,
    7. Baldwin RM,
    8. Schwartzman AN,
    9. Shelby ES,
    10. Smith CE,
    11. Kessler RM,
    12. Zald DH
    (2010) Dopaminergic network differences in human impulsivity. Science 329:532, doi:10.1126/science.1185778, pmid:20671181.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Cherek DR,
    2. Spiga R,
    3. Steinberg JL,
    4. Kelly TH
    (1990) Human aggressive responses maintained by avoidance or escape from point loss. J Exp Anal Behav 53:293–303, doi:10.1901/jeab.1990.53-293, pmid:2324668.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Cherek DR,
    2. Moeller FG,
    3. Schnapp W,
    4. Dougherty DM
    (1997) Studies of violent and nonviolent male parolees: I. Laboratory and psychometric measurements of aggression. Biol Psychiatry 41:514–522, doi:10.1016/S0006-3223(96)00059-5, pmid:9046983.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Cloninger CR
    (1994) Temperament and personality. Curr Opin Neurobiol 4:266–273, doi:10.1016/0959-4388(94)90083-3, pmid:8038587.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Cloninger CR,
    2. Pryzbeck TR,
    3. Svrakic DM,
    4. Wetzel RD
    (1999) Das Temperament- und Charakter-Inventar (TCI) (Swets and Zeitlinger, Frankfurt).
  12. ↵
    1. Coccaro EF,
    2. Berman ME,
    3. Kavoussi RJ,
    4. Hauger RL
    (1996) Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry 40:157–164, doi:10.1016/0006-3223(95)00398-3, pmid:8830948.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Cocker PJ,
    2. Dinelle K,
    3. Kornelson R,
    4. Sossi V,
    5. Winstanley CA
    (2012) Irrational choice under uncertainty correlates with lower striatal D2/3 receptor binding in rats. J Neurosci 32:15450–15457, doi:10.1523/JNEUROSCI.0626-12.2012, pmid:23115182.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Couppis MH,
    2. Kennedy CH
    (2008) The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice. Psychopharmacology 197:449–456, doi:10.1007/s00213-007-1054-y, pmid:18193405.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Cumming P,
    2. Gjedde A
    (1998) Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 29:37–61, doi:10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO%3B2-C, pmid:9552174.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Cumming P,
    2. Léger GC,
    3. Kuwabara H,
    4. Gjedde A
    (1993) Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans. J Cereb Blood Flow Metab 13:668–675, doi:10.1038/jcbfm.1993.85, pmid:8314919.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Dalley JW,
    2. Roiser JP
    (2012) Dopamine, serotonin and impulsivity. Neuroscience 215:42–58, doi:10.1016/j.neuroscience.2012.03.065, pmid:22542672.
    OpenUrlCrossRefPubMed
  18. ↵
    1. de Bruijn ER,
    2. de Lange FP,
    3. von Cramon DY,
    4. Ullsperger M
    (2009) When errors are rewarding. J Neurosci 29:12183–12186, doi:10.1523/JNEUROSCI.1751-09.2009, pmid:19793976.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Ernst M,
    2. Nelson EE,
    3. McClure EB,
    4. Monk CS,
    5. Munson S,
    6. Eshel N,
    7. Zarahn E,
    8. Leibenluft E,
    9. Zametkin A,
    10. Towbin K,
    11. Blair J,
    12. Charney D,
    13. Pine DS
    (2004) Choice selection and reward anticipation: an fMRI study. Neuropsychologia 42:1585–1597, doi:10.1016/j.neuropsychologia.2004.05.011, pmid:15327927.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Ferrari PF,
    2. van Erp AM,
    3. Tornatzky W,
    4. Miczek KA
    (2003) Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci 17:371–378, doi:10.1046/j.1460-9568.2003.02447.x, pmid:12542674.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Frankle WG,
    2. Lombardo I,
    3. New AS,
    4. Goodman M,
    5. Talbot PS,
    6. Huang Y,
    7. Hwang DR,
    8. Slifstein M,
    9. Curry S,
    10. Abi-Dargham A,
    11. Laruelle M,
    12. Siever LJ
    (2005) Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 162:915–923, doi:10.1176/appi.ajp.162.5.915, pmid:15863793.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Gjedde A,
    2. Reith J,
    3. Dyve S,
    4. Léger G,
    5. Guttman M,
    6. Diksic M,
    7. Evans A,
    8. Kuwabara H
    (1991) Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci U S A 88:2721–2725, doi:10.1073/pnas.88.7.2721, pmid:1688340.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Golomb BA,
    2. Cortez-Perez M,
    3. Jaworski BA,
    4. Mednick S,
    5. Dimsdale J
    (2007) Point subtraction aggression paradigm: validity of a brief schedule of use. Violence Vict 22:95–103, doi:10.1891/vv-v22i1a006, pmid:17390565.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Greenwald MK,
    2. Chiodo LM,
    3. Hannigan JH,
    4. Sokol RJ,
    5. Janisse J,
    6. Delaney-Black V
    (2011) Teens with heavy prenatal cocaine exposure respond to experimental social provocation with escape not aggression. Neurotoxicol Teratol 33:198–204, doi:10.1016/j.ntt.2010.06.008, pmid:20600841.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Gründer G,
    2. Fellows C,
    3. Janouschek H,
    4. Veselinovic T,
    5. Boy C,
    6. Bröcheler A,
    7. Kirschbaum KM,
    8. Hellmann S,
    9. Spreckelmeyer KM,
    10. Hiemke C,
    11. Rösch F,
    12. Schaefer WM,
    13. Vernaleken I
    (2008) Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study. Am J Psychiatry 165:988–995, doi:10.1176/appi.ajp.2008.07101574, pmid:18381901.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Hare RD,
    2. Hart SD,
    3. Harpur TJ
    (1991) Psychopathy and the DSM-IV criteria for antisocial personality disorder. J Abnorm Psychol 100:391–398, doi:10.1037/0021-843X.100.3.391, pmid:1918618.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Henry DB,
    2. Study Research Group TMAC
    (2006) Associations between peer nominations, teacher ratings, self-reports, and observations of malicious and disruptive behavior. Assessment 13:241–252, doi:10.1177/1073191106287668, pmid:16880277.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Huang SC,
    2. Yu DC,
    3. Barrio JR,
    4. Grafton S,
    5. Melega WP,
    6. Hoffman JM,
    7. Satyamurthy N,
    8. Mazziotta JC,
    9. Phelps ME
    (1991) Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies. J Cereb Blood Flow Metab 11:898–913, doi:10.1038/jcbfm.1991.155, pmid:1939385.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Joutsa J,
    2. Johansson J,
    3. Niemelä S,
    4. Ollikainen A,
    5. Hirvonen MM,
    6. Piepponen P,
    7. Arponen E,
    8. Alho H,
    9. Voon V,
    10. Rinne JO,
    11. Hietala J,
    12. Kaasinen V
    (2012) Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 60:1992–1999, doi:10.1016/j.neuroimage.2012.02.006, pmid:22348881.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Kayser AS,
    2. Allen DC,
    3. Navarro-Cebrian A,
    4. Mitchell JM,
    5. Fields HL
    (2012) Dopamine, corticostriatal connectivity, and intertemporal choice. J Neurosci 32:9402–9409, doi:10.1523/JNEUROSCI.1180-12.2012, pmid:22764248.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Kouri EM,
    2. Pope HG Jr.,
    3. Lukas SE
    (1999) Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 143:302–308, doi:10.1007/s002130050951, pmid:10353434.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Kumakura Y,
    2. Vernaleken I,
    3. Gründer G,
    4. Bartenstein P,
    5. Gjedde A,
    6. Cumming P
    (2005) PET studies of net blood–brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity. J Cereb Blood Flow Metab 25:807–819, doi:10.1038/sj.jcbfm.9600079, pmid:15729292.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Kumakura Y,
    2. Gjedde A,
    3. Danielsen EH,
    4. Christensen S,
    5. Cumming P
    (2006) Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms. J Cereb Blood Flow Metab 26:358–370, doi:10.1038/sj.jcbfm.9600202, pmid:16079784.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Kumakura Y,
    2. Cumming P,
    3. Vernaleken I,
    4. Buchholz HG,
    5. Siessmeier T,
    6. Heinz A,
    7. Kienast T,
    8. Bartenstein P,
    9. Gründer G
    (2007) Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study. J Neurosci 27:8080–8087, doi:10.1523/JNEUROSCI.0805-07.2007, pmid:17652599.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. Licata A,
    2. Taylor S,
    3. Berman M,
    4. Cranston J
    (1993) Effects of cocaine on human aggression. Pharmacol Biochem Behav 45:549–552, doi:10.1016/0091-3057(93)90504-M, pmid:8332615.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Linnet J,
    2. Møller A,
    3. Peterson E,
    4. Gjedde A,
    5. Doudet D
    (2011) Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 106:383–390, pmid:20883460.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Linnet J,
    2. Mouridsen K,
    3. Peterson E,
    4. Møller A,
    5. Doudet DJ,
    6. Gjedde A
    (2012) Striatal dopamine release codes uncertainty in pathological gambling. Psychiatry Res 204:55–60, doi:10.1016/j.pscychresns.2012.04.012, pmid:22889563.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Linnoila M,
    2. Virkkunen M,
    3. Scheinin M,
    4. Nuutila A,
    5. Rimon R,
    6. Goodwin FK
    (1983) Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33:2609–2614, doi:10.1016/0024-3205(83)90344-2, pmid:6198573.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Ludolph AG,
    2. Kassubek J,
    3. Schmeck K,
    4. Glaser C,
    5. Wunderlich A,
    6. Buck AK,
    7. Reske SN,
    8. Fegert JM,
    9. Mottaghy FM
    (2008) Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study. Neuroimage 41:718–727, doi:10.1016/j.neuroimage.2008.02.025, pmid:18424180.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Mazziotta J,
    2. Toga A,
    3. Evans A,
    4. Fox P,
    5. Lancaster J,
    6. Zilles K,
    7. Woods R,
    8. Paus T,
    9. Simpson G,
    10. Pike B,
    11. Holmes C,
    12. Collins L,
    13. Thompson P,
    14. MacDonald D,
    15. Iacoboni M,
    16. Schormann T,
    17. Amunts K,
    18. Palomero-Gallagher N,
    19. Geyer S,
    20. Parsons L,
    21. et al.
    (2001) A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 356:1293–1322, doi:10.1098/rstb.2001.0915, pmid:11545704.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Moeller FG,
    2. Dougherty DM,
    3. Swann AC,
    4. Collins D,
    5. Davis CM,
    6. Cherek DR
    (1996) Tryptophan depletion and aggressive responding in healthy males. Psychopharmacology 126:97–103, doi:10.1007/BF02246343, pmid:8856827.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Morgan D,
    2. Grant KA,
    3. Gage HD,
    4. Mach RH,
    5. Kaplan JR,
    6. Prioleau O,
    7. Nader SH,
    8. Buchheimer N,
    9. Ehrenkaufer RL,
    10. Nader MA
    (2002) Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 5:169–174, doi:10.1038/nn798, pmid:11802171.
    OpenUrlCrossRefPubMed
  43. ↵
    1. New AS,
    2. Hazlett EA,
    3. Newmark RE,
    4. Zhang J,
    5. Triebwasser J,
    6. Meyerson D,
    7. Lazarus S,
    8. Trisdorfer R,
    9. Goldstein KE,
    10. Goodman M,
    11. Koenigsberg HW,
    12. Flory JD,
    13. Siever LJ,
    14. Buchsbaum MS
    (2009) Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol Psychiatry 66:1107–1114, doi:10.1016/j.biopsych.2009.07.015, pmid:19748078.
    OpenUrlCrossRefPubMed
  44. ↵
    1. O'Doherty JP,
    2. Deichmann R,
    3. Critchley HD,
    4. Dolan RJ
    (2002) Neural responses during anticipation of a primary taste reward. Neuron 33:815–826, doi:10.1016/S0896-6273(02)00603-7, pmid:11879657.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Oei NY,
    2. Rombouts SA,
    3. Soeter RP,
    4. van Gerven JM,
    5. Both S
    (2012) Dopamine modulates reward system activity during subconscious processing of sexual stimuli. Neuropsychopharmacology 37:1729–1737, doi:10.1038/npp.2012.19, pmid:22395731.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Oswald LM,
    2. Wong DF,
    3. Zhou Y,
    4. Kumar A,
    5. Brasic J,
    6. Alexander M,
    7. Ye W,
    8. Kuwabara H,
    9. Hilton J,
    10. Wand GS
    (2007) Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 36:153–166, doi:10.1016/j.neuroimage.2007.01.055, pmid:17433881.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Pope HG Jr.,
    2. Kouri EM,
    3. Hudson JI
    (2000) Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry 57:133–140, doi:10.1001/archpsyc.57.2.133, pmid:10665615, discussion 155–156.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Rademacher L,
    2. Krach S,
    3. Kohls G,
    4. Irmak A,
    5. Gründer G,
    6. Spreckelmeyer KN
    (2010) Dissociation of neural networks for anticipation and consumption of monetary and social rewards. Neuroimage 49:3276–3285, doi:10.1016/j.neuroimage.2009.10.089, pmid:19913621.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Raine A,
    2. Dodge K,
    3. Loeber R,
    4. Gatzke-Kopp L,
    5. Lynam D,
    6. Reynolds C,
    7. Stouthamer-Loeber M,
    8. Liu J
    (2006) The reactive–proactive aggression questionnaire: differential correlates of reactive and proactive aggression in adolescent boys. Aggress Behav 32:159–171, doi:10.1002/ab.20115, pmid:20798781.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Ramírez-Bermudez J,
    2. Perez-Neri I,
    3. Montes S,
    4. Ramirez-Abascal M,
    5. Nente F,
    6. Abundes-Corona A,
    7. Soto-Hernandez JL,
    8. Rios C
    (2010) Imbalance between nitric oxide and dopamine may underly aggression in acute neurological patients. Neurochem Res 35:1659–1665, doi:10.1007/s11064-010-0227-y, pmid:20680461.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Rodrigo C,
    2. Rajapakse S,
    3. Jayananda G
    (2010) The ‘antisocial’ person: an insight in to biology, classification and current evidence on treatment. Ann Gen Psychiatry 9:31, doi:10.1186/1744-859X-9-31, pmid:20604959.
    OpenUrlCrossRefPubMed
  52. ↵
    1. Rylands AJ,
    2. Hinz R,
    3. Jones M,
    4. Holmes SE,
    5. Feldmann M,
    6. Brown G,
    7. McMahon AW,
    8. Talbot PS
    (2012) Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using 11C-DASB and 11C-MDL100907. Biol Psychiatry 72:1004–1011, doi:10.1016/j.biopsych.2012.06.024, pmid:22835812.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Salokangas RK,
    2. Vilkman H,
    3. Ilonen T,
    4. Taiminen T,
    5. Bergman J,
    6. Haaparanta M,
    7. Solin O,
    8. Alanen A,
    9. Syvälahti E,
    10. Hietala J
    (2000) High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry 157:632–634, doi:10.1176/appi.ajp.157.4.632, pmid:10739427.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Schabram I,
    2. Prinz S,
    3. Henkel K,
    4. Dietrich CA,
    5. Felzen M,
    6. Winz O,
    7. Shali SM,
    8. Gründer G,
    9. Mottaghy FM,
    10. Vernaleken I
    (2013) International Society for Cerebral Blood Flow and Metabolism (May 20–23, Shanghai, China), Impact of acute methylphenidate challenge on presynaptic dopamine metabolism: an [18F]FDOPA PET study.
  55. ↵
    1. Schultz W
    (2002) Getting formal with dopamine and reward. Neuron 36:241–263, doi:10.1016/S0896-6273(02)00967-4, pmid:12383780.
    OpenUrlCrossRefPubMed
  56. ↵
    1. Soderstrom H,
    2. Blennow K,
    3. Manhem A,
    4. Forsman A
    (2001) CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy. J Neural Transm 108:869–878, doi:10.1007/s007020170036, pmid:11515752.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Sossi V,
    2. Doudet DJ,
    3. Holden JE
    (2001) A reversible tracer analysis approach to the study of effective dopamine turnover. J Cereb Blood Flow Metab 21:469–476, pmid:11323532.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Takahashi H,
    2. Kato M,
    3. Matsuura M,
    4. Mobbs D,
    5. Suhara T,
    6. Okubo Y
    (2009) When your gain is my pain and your pain is my gain: neural correlates of envy and schadenfreude. Science 323:937–939, doi:10.1126/science.1165604, pmid:19213918.
    OpenUrlAbstract/FREE Full Text
  59. ↵
    1. Tripp G,
    2. Wickens JR
    (2008) Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD. J Child Psychol Psychiatry 49:691–704, doi:10.1111/j.1469-7610.2007.01851.x, pmid:18081766.
    OpenUrlCrossRefPubMed
  60. ↵
    1. Vernaleken I,
    2. Kumakura Y,
    3. Cumming P,
    4. Buchholz HG,
    5. Siessmeier T,
    6. Stoeter P,
    7. Müller MJ,
    8. Bartenstein P,
    9. Gründer G
    (2006) Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge. Neuroimage 30:1332–1339, doi:10.1016/j.neuroimage.2005.11.014, pmid:16439159.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Vernaleken I,
    2. Buchholz HG,
    3. Kumakura Y,
    4. Siessmeier T,
    5. Stoeter P,
    6. Bartenstein P,
    7. Cumming P,
    8. Gründer G
    (2007) ‘Prefrontal’ cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation. Hum Brain Mapp 28:931–939, doi:10.1002/hbm.20325, pmid:17133402.
    OpenUrlCrossRefPubMed
  62. ↵
    1. Vernaleken I,
    2. Kumakura Y,
    3. Buchholz HG,
    4. Siessmeier T,
    5. Hilgers RD,
    6. Bartenstein P,
    7. Cumming P,
    8. Gründer G
    (2008) Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: a positron emission tomography study in healthy subjects. Neuroimage 40:1222–1231, doi:10.1016/j.neuroimage.2007.12.045, pmid:18262797.
    OpenUrlCrossRefPubMed
  63. ↵
    1. Vitiello B,
    2. Stoff DM
    (1997) Subtypes of aggression and their relevance to child psychiatry. J Am Acad Child Adolesc Psychiatry 36:307–315, doi:10.1097/00004583-199703000-00008, pmid:9055510.
    OpenUrlCrossRefPubMed
  64. ↵
    1. Witte AV,
    2. Flöel A,
    3. Stein P,
    4. Savli M,
    5. Mien LK,
    6. Wadsak W,
    7. Spindelegger C,
    8. Moser U,
    9. Fink M,
    10. Hahn A,
    11. Mitterhauser M,
    12. Kletter K,
    13. Kasper S,
    14. Lanzenberger R
    (2009) Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum Brain Mapp 30:2558–2570, doi:10.1002/hbm.20687, pmid:19086022.
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 33 (43)
Journal of Neuroscience
Vol. 33, Issue 43
23 Oct 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Impact of Dopamine on Aggression: An [18F]-FDOPA PET Study in Healthy Males
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
The Impact of Dopamine on Aggression: An [18F]-FDOPA PET Study in Healthy Males
Thorben Schlüter, Oliver Winz, Karsten Henkel, Susanne Prinz, Lena Rademacher, Jörn Schmaljohann, Kai Dautzenberg, Paul Cumming, Yoshitaka Kumakura, Steffen Rex, Felix M. Mottaghy, Gerhard Gründer, Ingo Vernaleken
Journal of Neuroscience 23 October 2013, 33 (43) 16889-16896; DOI: 10.1523/JNEUROSCI.1398-13.2013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
The Impact of Dopamine on Aggression: An [18F]-FDOPA PET Study in Healthy Males
Thorben Schlüter, Oliver Winz, Karsten Henkel, Susanne Prinz, Lena Rademacher, Jörn Schmaljohann, Kai Dautzenberg, Paul Cumming, Yoshitaka Kumakura, Steffen Rex, Felix M. Mottaghy, Gerhard Gründer, Ingo Vernaleken
Journal of Neuroscience 23 October 2013, 33 (43) 16889-16896; DOI: 10.1523/JNEUROSCI.1398-13.2013
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles

Behavioral/Cognitive

  • Pulvinar Response Profiles and Connectivity Patterns to Object Domains
  • Subtype-Specific Roles of Ellipsoid Body Ring Neurons in Sleep Regulation in Drosophila
  • Proprioceptive and Visual Feedback Responses in Macaques Exploit Goal Redundancy
Show more Behavioral/Cognitive
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.